Mitotic Exit
Mitotic Exit is the biochemical transition within the cell cycle that marks the shift from mitotic phase to G1 phase, distinguished by cyclin B1 degradation, inactivation of mitotic kinases, and reformation of decondensed nuclei in daughter cells.
1.4K
Publications
110.5K
Citations
5.5K
Authors
1.3K
Institutions
Publications per year
2017–2026
155
1.4K
1–5 of 1.4K
5.5K
21
h-index
14
h-index
11
h-index
11
h-index
The University of Texas Southwestern Medical Center, United States
11 publications · 2.1K citations
11
h-index
1–5 of 5.5K
1.3K

Howard Hughes Medical Institute
Chevy Chase, United States
47 h-index
186 publications
24.4K citations
Harvard University
Cambridge, United States
44 h-index
190 publications
34.7K citations

Centre National de la Recherche Scientifique
Paris, France
39 h-index
241 publications
23.9K citations
Massachusetts Institute of Technology
Cambridge, United States
25 h-index
70 publications
8.5K citations
University of Oxford
Oxford, United Kingdom
25 h-index
87 publications
8.4K citations

Cancer Research UK
London, United Kingdom
22 h-index
48 publications
5.3K citations
Stanford University
Stanford, United States
22 h-index
76 publications
10.8K citations
University of California, San Francisco
San Francisco, United States
21 h-index
67 publications
7.6K citations
1–8 of 1.3K
JCB · 94 publications · 10.8K citations
60
h-index
MBC · 79 publications · 6.3K citations
43
h-index
MCB · 59 publications · 5.5K citations
42
h-index
73 publications · 4.2K citations
40
h-index
JBC · 60 publications · 4.5K citations
39
h-index
1–5